Vivimed Labs
Vivimed Labs Performance
Day Range
- Low 4.85
- High 5.25
52 Week Range
- Low 4.85
- High 13.95
- Open Price5.25
- Previous Close5
- Volume151690
Start SIP in Vivimed Labs
Start SIPVivimed Labs Investment Rating
-
Master Rating:
-
Vivimed Labs has an operating revenue of Rs. 172.34 Cr. on a trailing 12-month basis. An annual revenue de-growth of -21% needs improvement, Pre-tax margin of -177% needs improvement, ROE of -833% is poor and needs improvement. The company has a high debt to equity of 158%, which can be a reason to worry. From an O'Neil Methodology perspective, the stock has an EPS Rank of 17 which is a POOR score indicating inconsistency in earnings, a RS Rating of 2 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 111 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of E is the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 33 | 40 | 51 | 39 | 47 | 53 |
Operating Expenses Qtr Cr | 33 | 203 | 57 | 49 | 56 | 55 |
Operating Profit Qtr Cr | 0 | -164 | -6 | -10 | -9 | -2 |
Depreciation Qtr Cr | 4 | 95 | 4 | 4 | 4 | 5 |
Interest Qtr Cr | 11 | 8 | 9 | 9 | 9 | 10 |
Tax Qtr Cr | 0 | -2 | 0 | 0 | 0 | 3 |
Net Profit Qtr Cr | -15 | -265 | -19 | -22 | -22 | -19 |
Vivimed Labs Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹6.14
- 50 Day
- ₹7.75
- 100 Day
- ₹8.95
- 200 Day
- ₹10.75
- 20 Day
- ₹5.94
- 50 Day
- ₹8.6
- 100 Day
- ₹9.31
- 200 Day
- ₹10.15
Vivimed Labs Resistance and Support
Resistance | |
---|---|
First Resistance | ₹5.19 |
Second Resistance | ₹5.42 |
Third Resistance | ₹5.59 |
RSI | 16.77 |
MFI | 11.32 |
MACD Single Line | -1.03 |
MACD | -0.98 |
Support | |
---|---|
First Resistance | ₹4.79 |
Second Resistance | ₹4.62 |
Third Resistance | ₹4.39 |
Vivimed Labs Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | |||
Week | |||
1 Month | |||
6 Month | 25,668 | 2,566,785 | 100 |
Vivimed Labs Result Highlights
Vivimed Labs Synopsis
NSE-Medical-Diversified
Vivimed Labs is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 176.83 Cr. and Equity Capital is Rs. 16.58 Cr. for the Year ended 31/03/2023. Vivimed Labs Ltd. is a Public Limited Listed company incorporated on 22/09/1988 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L02411KA1988PLC009465 and registration number is 009465.Market Cap | 41 |
Sales | 162 |
Shares in Float | 6.55 |
No of funds | 5 |
Yield |
Book Value | 0.31 |
U/D Vol ratio | |
LTDebt / Equity | 46 |
Alpha | -0.61 |
Beta | -0.02 |
Vivimed Labs
Owner Name | Jun-23 | Mar-23 | Dec-22 | Sep-22 |
---|---|---|---|---|
Promoters | 20.94% | 20.94% | 20.96% | 20.96% |
Foreign Portfolio Investors | 1.64% | 1.64% | 1.64% | 1.64% |
Individual Investors | 57% | 57.08% | 57.03% | 57.64% |
Others | 20.42% | 20.34% | 20.37% | 19.76% |
Vivimed Labs Management
Name | Designation |
---|---|
Dr. Jamalapuram Harigopal | Chairman & Ind.Director |
Mr. Santosh Varalwar | Managing Director |
Dr. Manohar Rao Varalwar | Whole Time Director |
Mr. Sandeep Varalwar | Whole Time Director |
Mr. Subhash Varalwar | Non Executive Director |
Vivimed Labs Forecast
Price Estimates
Vivimed Labs Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-08-14 | Quarterly Results | |
2023-05-30 | Quarterly Results | |
2023-02-13 | Quarterly Results | |
2023-01-13 | A.G.M. | |
2022-08-12 | Quarterly Results |
- Company Name
- CMP
- Chg(%)
- Hindalco Inds.
- 493
- 5.5
- NTPC
- 246
- 3.6
- Hero Motocorp
- 3057
- 2.9
- Dr Reddys Labs
- 5587
- 2.9
- Divis Lab.
- 3765
- 2.7
- Company Name
- CMP
- Chg(%)
- Adani Enterp.
- 2414
- -2.5
- LTIMindtree
- 5210
- -1.0
- HCL Technologies
- 1235
- -0.6
- Tech Mahindra
- 1223
- -0.5
- Power Grid Corpn
- 200
- -0.5
Vivimed Labs FAQs
What is Share Price of Vivimed Labs ?
Vivimed Labs share price is ₹4 As on 30 September, 2023 | 05:17
What is the Market Cap of Vivimed Labs ?
The Market Cap of Vivimed Labs is ₹40.6 Cr As on 30 September, 2023 | 05:17
What is the P/E ratio of Vivimed Labs ?
The P/E ratio of Vivimed Labs is -0.1 As on 30 September, 2023 | 05:17
What is the PB ratio of Vivimed Labs ?
The PB ratio of Vivimed Labs is 1 As on 30 September, 2023 | 05:17